CYTHCyclo Therapeutics, Inc.

Nasdaq cyclotherapeutics.com


$ 1.25 $ 0.02 (1.63 %)    

Wednesday, 21-Aug-2024 14:20:42 EDT
QQQ $ 482.29 $ 1.17 (0.24 %)
DIA $ 409.02 $ -0.21 (-0.05 %)
SPY $ 560.54 $ 0.61 (0.11 %)
TLT $ 98.78 $ 0.10 (0.1 %)
GLD $ 232.34 $ 0.68 (0.29 %)
$ 1.23
$ 1.23
$ 1.24 x 100
-- x --
$ 1.23 - $ 1.25
$ 0.89 - $ 2.12
12,816
na
35.3M
$ -0.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-18-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-17-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-11-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-12-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-15-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 04-16-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-11-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-17-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-12-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 05-15-2015 03-31-2015 10-Q
39 03-27-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-cyclo-therapeutics-maintains-3-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

 cyclo-therapeutics-q2-eps-021-misses-016-estimate-sales-12310k-miss-26750k-estimate

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of ...

 cyclo-therapeutics-has-been-granted-european-patent-number-ep3873604-titled-methods-for-treating-alzheimers-disease-with-hp-beta-cyclodextrin

https://register.epo.org/application?number=EP19805439

 hc-wainwright--co-reiterates-buy-on-cyclo-therapeutics-maintains-3-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

 cyclo-therapeutics-completes-last-patient-in-phase-3-transportnpc-trial-of-niemann-pick-type-c1

TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and...

 cyclo-therapeutics-q1-2024-gaap-eps-015-beats-019-estimate-sales-202450k-miss-376667k-estimate

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-initiates-coverage-on-cyclo-therapeutics-with-buy-rating-announces-price-target-of-3

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rat...

 ascendiant-capital-initiates-coverage-on-cyclo-therapeutics-with-buy-rating-announces-price-target-of-26

Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces...

 cyclo-therapeutics-receives-decision-to-grant-european-patent-titled-methods-for-treating-alzheimers-disease-with-hp-beta-cyclodextrin

https://register.epo.org/application?number=EP19805439

 cyclo-therapeutics-announces-issuance-of-us-patent-covering-the-use-of-trappsol-cyclo-for-the-treatment-of-alzheimers-disease

Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology ...

 why-douyu-international-shares-are-trading-higher-by-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share ...

 why-bridgeline-digital-shares-are-trading-lower-by-13-here-are-20-stocks-moving-premarket

Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION